Skip to main content

Conventional and Clinimetric Approaches to Individualization of Antiepileptic Drug Therapy

  • Chapter

Part of the book series: NATO ASI Series ((NSSA,volume 255))

Abstract

The goal of the physician treating an individual patient with epilepsy is to help them to achieve the best quality of life possible, by careful tailoring of their antiepileptic drug (AED) treatment and attention to the wider implications of epilepsy.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Baker GA, Smith DF, Dewey M, Morrow J, Crawford PM, Chadwick DW. The development of a seizure severity scale as an outcome measure in epilepsy. Epilepsy Res 1991; 8: 245–251.

    Article  PubMed  CAS  Google Scholar 

  • Cereghino JJ, Brock JT, Van Meter JC et al. Evaluation of albutoin as an antiepileptic drug. Clin Pharmacol Ther 1974; 15: 406–416.

    PubMed  CAS  Google Scholar 

  • Cramer JA, Smith DB, Mattson RH et al. A method of quantification for the evaluation of antiepileptic drug therapy. Neurology 1983; 33 (suppl 1): 26–37.

    Article  PubMed  CAS  Google Scholar 

  • Duncan JS. Medical factors affecting quality of life in patients with epilepsy. In: Chadwick DW., ed. Quality of life and quality of care in epilepsy. Royal Society of Medicine Round Table Series 1990; 23: 80–87.

    Google Scholar 

  • Duncan JS, Sander JWAS. The Chalfont seizure severity scale. J Neurol Neurosurg Psychiat 1991; 54: 873–876.

    Article  PubMed  CAS  Google Scholar 

  • Gruber CM, Mosier JM, Grant P. Objective comparison of primidone and phenobarbitone in epileptics. J Pharmacol Exp Ther 1957; 120: 184–187.

    PubMed  CAS  Google Scholar 

  • Shofer JB, Temkin NR. Comparison of alternative outcome measures for antiepileptic drug trials. Arch Neurol 1986; 43: 877–881.

    Article  PubMed  CAS  Google Scholar 

  • Smith D, Baker GA, Dewey M, Chadwick DW. Seizure severity scale as an outcome measure in a double-blind cross-over trial of lamotrigine as add-on therapy in patients with refractory epilepsy. Epilepsia 1991; 32 (suppl 1): 95.

    Google Scholar 

  • Vickrey BG, Hays RD, Herman B, Batzel L. Quality of life outcomes. In: Engel J, Jr., ed. Surgical treatment of the epilepsies, 2nd edition, Raven Press, New York, 1993.

    Google Scholar 

  • Wijsman DJP, Hekster YA, Keyser A, Renier WO, Meinardi H. Clinimetrics and epilepsy care. Pharmaceutisch Weekblad Scientific edition 1991; 13: 182–188.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Duncan, J.S. (1993). Conventional and Clinimetric Approaches to Individualization of Antiepileptic Drug Therapy. In: Meinardi, H., Cramer, J.A., Baker, G.A., da Silva, A.M. (eds) Quantitative Assessment in Epilepsy Care. NATO ASI Series, vol 255. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2990-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2990-3_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6302-6

  • Online ISBN: 978-1-4615-2990-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics